Showing results (31-40 of 222) with videos related to

Sort By:
Pageof 23
Biochemical and Biophysical Research Communications|August 24, 1995
Crucial role of c-myc in 1,25(OH)2D3 control of C-cell-carcinoma proliferationA Grauer, R Baier, R Ziegler, et al.
Thyroid : Official Journal of the American Thyroid Association|August 1, 1995
Evaluation of somatostatin as a plasma tumor marker in medullary thyroid carcinomaA Grauer, J Schroth, R Ziegler, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 18, 2010
Are commonly recommended dosages for vitamin D supplementation too low? Vitamin D status and effects of supplementation on serum 25-hydroxyvitamin D levels--an observational study during clinical practice conditionsG Leidig-Bruckner, H J Roth, T Bruckner, et al.
Molecular and Cellular Endocrinology|July 9, 1990
1,25-Dihydroxyvitamin D3 suppresses dexamethasone effects on calcitonin secretionM Lazaretti-Castro, A Grauer, F Raue, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 1, 1992
Regulation of calcitonin gene expression by hypocalcemia, hypercalcemia, and vitamin D in the ratT Naveh-Many, F Raue, A Grauer, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|September 1, 1993
Neutralizing antibodies against calcitoninA Grauer, H H Reinel, R Ziegler, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1987
Neuron-specific enolase in medullary thyroid carcinoma: immunohistochemical demonstration, but no significance as serum tumor markerA Grauer, F Raue, E Rix, et al.
Nuclear Medicine Communications|June 1, 1993
The potential value of somatostatin receptor scintigraphy in medullary thyroid carcinomaU Dörr, K Frank-Raue, F Raue, et al.
Deutsche Medizinische Wochenschrift (1946)|September 15, 2011
[Hereditary variants of primary hyperparathyroidism--MEN1, MEN2, HPT-JT, FHH, FIHPT]K Frank-Raue, G Leidig-Bruckner, A Lorenz, et al.
Pageof 23